Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in New Drug Approvals

FDA Approves Zerbaxa (ceftolozane/tazobactam) for Complicated Intra-Abdominal/Urinary Tract Infections

The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI). Zerbaxa is a combination product containing ceftolozane, a cephalosporin antibacterial drug, and tazobactam, a beta-lactamase...

Posted today in Pharma Industry News

FDA approves pathogen reduction system to treat platelets

The U.S. Food and Drug Administration yesterday approved the Intercept Blood System for platelets, the first pathogen reduction system to treat single donor apheresis platelets. The system is for use by blood establishments that collect and manufacture blood and blood components to prepare pathogen reduced platelets for transfusion to reduce the risk...

Posted 3 days ago in New Drug Approvals

Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly

EAST HANOVER, N.J., Dec. 16, 2014 Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor long-acting release (LAR)* (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option....

Posted 3 days ago in New Drug Approvals

FDA Approves Xtoro (finafloxacin) Otic Suspension to Treat Swimmer’s Ear

The U.S. Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer’s ear. Acute otitis externa is an infection in the outer ear and ear canal, usually caused by bacteria in the ear canal. Activities in which the ear is underwater can create a moist environment...

Posted 2 days ago in Clinical Trials

Tetraphase Announces Positive Top-line Results from Phase 3 IGNITE 1 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections

(BUSINESS WIRE)-- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced positive top-line results from IGNITE 1, the Company's Phase 3 clinical trial of eravacycline for the treatment of complicated intra-abdominal...

Posted today in Medical

Holiday Trimmings Can Trigger Allergies

The holidays can be anything but joyous for people with allergies when they contend with fresh trees, scented candles and other allergy triggers. "The dust from the boxes and on the decorations that have been packed away in dank basements or dusty attics is triggering reactions in my allergy and asthma patients," Dr. Rachna Shah, an affiliate faculty...

Posted yesterday in Medical

Study Supports Benefit of Widely Used Glaucoma Drug

Prostaglandin analogue eye drops -- a common form of glaucoma drug -- significantly reduce the risk of vision loss in patients with the eye disease, a new study finds. British researchers led by David Garway-Heath, of the Moorfields Eye Hospital and UCL Institute of Ophthalmology in London, tracked outcomes for more than 500 people newly diagnosed...

Posted yesterday in Medical

Some Blood Types Might Raise Type 2 Diabetes Risk: Study

In what scientists say is a first, a new analysis suggests that some blood types place women at a higher risk for developing type 2 diabetes. How much higher? According to a team of French researchers, women with blood type B positive appear to face a 35 percent greater risk for developing type 2 diabetes than women with blood type O negative. However,...

Posted yesterday in Medical

Health Highlights: Dec. 19, 2014

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Many Doctors Hit With Medicare Payment Cuts Hundreds of thousands of American doctors will have their Medicare payments cut next year because they haven't met specified goals, federal officials say. More than 257,000 doctors will have their payments...

Posted yesterday in Medical

Cancer Treatment Costs Weigh Heavily on Patients, Study Finds

The cost of cancer treatment can cause financial stress that threatens patients' well-being, a new study finds. Researchers examined data from 1,000 people in the United States who had been diagnosed with colorectal or lung cancer. Of those patients, almost 900 had finished their treatments and were cancer-free, and more than 100 had advanced cancer. Nearly...

Read more news...

Recently added consumer and prescribing information: Xigduo XR, Ofev, Esbriet, Harvoni, Akynzeo, Tybost, Vitekta, Trulicity, Movantik, Contrave

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

Posted in Blog

Fox News Features Drugs.com Medication Guide app

Thanks to Fox News for showcasing the Drugs.com Medication Guide app today. Very much appreciated. Available in both the Apple App store and the Google Play store, this is a great app for ultra-quick research and/or keeping track of multiple meds. Check out the video at the link below… http://www.foxnews.com/health/2014/07/13/drugscom-app-provides-medical-information-on-go/ And check out the apps here… http://www.drugs.com/apps/

Posted in Blog

Heartbleed Update

Drugs.com utilizes the Akamai content delivery network to serve our website to end users. Akamai patched the announced Heartbleed vulnerability prior to its public announcement. Akamai, like all users of OpenSSL, could have exposed passwords or session cookies transiting our network from August 2012 through 4 April 2014. Their custom memory allocator protected against nearly […]

See more blog posts or follow us on twitter.

Hide
(web4)